why we invest in greece and cyprus (now!)
MARKET EVIDENCE (TIMELINE)
Pre 2018 Indications
China created a new "Silk Road" in Greece (BBC News, October 2017).
Investors world wide (Brevan Howard etc) "re-discovered" Greece (Bloomberg, December 2017).
2018 Q1 Pre Ample
Middle East, like China, started investing in Greece direct and in funds (Reuters, March 2018).
2018 Q2 Market Movements
CVC makes multiple (Buy-and-Build) acquisitions in Greece, Metropolitan, Iaso, etc. (CVC, April 2018)
European investment arms are jumpstarting the ecosystem (European Commission, April 2018).
Greek business prospects brighten after a lost decade (Wall Street Journal, April 2018)
The Greek VC/Start up community is cultivating a knowledge economy (Reuters, May 2018).
Cyprus is expanding faster than official estimates (Xinhua, May 2018)
The Greek economy is recovering after a decade of struggles (OECD, May 2018).
History is made (CNBC, June 2018).
2018 Q3 Market Evidence
Greece emerges from eurozone bailout programme and returns to the markets (BBC, July 2018).
EU Moscovici says investors can now trust Greece (Bloomberg, July 2018).
CVC concludes another investment in Greece, with the acquisition of Hygeia Hospital (CVC, July 2018)
Greece eases capital controls, ends restrictions on cash withdrawals (Reuters, September 2018)
2018 Q4 Market U-Turn
IMF revised Greece’s 2019 Growth Rate Upwards (IMF, October 2018)
Athens is Awarded the European Capital of Innovation 2018 (European Commission, November 2018)
Brevan Howard (and hundreds of Chinese) enters Greek property market (Kathimerini, November 2018)
Brookstreet Equity Partners of London are actively investing in the future of Greece and Cyprus!
Brookstreet Equity Partners LLP UK is an EuVECA Manager and Member of the British Private Equity & Venture Capital Association (BVCA). Registered and Regulated by the Financial Conduct Authority (FCA).
Brookstreet Equity Partners LLP UK is a limited liability partnership, registered in England and Wales.
Registered Number OC413126. Registered Office: 42 Brook Street, Mayfair, London, W1K 5DB, UK.
All other Brookstreet locations, including worldwide offices, or any affiliates, constitute representation offices.
Disclaimer: This website is still under testing. Nothing contained on this website constitutes investment, legal, tax or any other advice. This website does not constitute an offer to sell or a solicitation of an offer to buy any company and no shares may be offered or sold, and no offers to buy shares may be solicited, in any jurisdiction in which, or to any person to which, such an offer, sale or solicitation is unlawful or unauthorized or would require registration.